refractory chronic cough Archives

SC Therapeutics launches REACH2 as SC0032 targets chronic cough beyond symptom control

by Pallavi Madhiraju
June 30, 2026
0 Comments

SC Therapeutics is advancing an unconventional soft-mist spray into a more rigorous UK study designed to test objective cough reduction, durability and the limits of an upstream airway-focused mechanism.

JAMA validates nalbuphine ER’s efficacy in IPF chronic cough as Trevi eyes next steps

Trevi’s IPF cough trial results for nalbuphine ER get published in JAMA. Find out what this means for future approvals and respiratory drug development.